BJH - volume 10, issue 2, march 2019
A. Jaspers MD, PhD, Y. Beguin MD, PhD
After haematopoietic stem cell transplantation (HCT), many patients present anaemia, which can persist for months due to an inadequate erythropoietin production for the degree of the anaemia. In this thesis, we performed two randomised studies with erythropoiesis-stimulating agents therapy after allogeneic (including myeloablative and non-myeloablative conditioning) and autologous transplantation. We showed a great efficacy of this growth factor to ensure full erythroid reconstitution when initiated soon after engraftment and not immediately after the transplant. Furthermore, as iron parameters are quite disturbed following HCT, we sought to study iron metabolism after HCT (which has not been much investigated), integrating the role of hepcidin, the key regulator in iron metabolism. Hence, we demonstrated that hepcidin levels prior to and following autologous HCT were influenced by iron stores and changes in erythropoietic activity.
(BELG J HEMATOL 2019;10(2):89–95)
Read moreBJH - volume 8, issue Abstract Book BHS, february 2017
A. Jaspers MD, PhD
BJH - volume 6, issue Abstract Book BHS, january 2015
A. Jaspers MD, PhD, F. Baron MD, PhD, J. Maertens MD, PhD, B. De Prijck MD, R. Schots MD, PhD, C. Bonnet MD, PhD, K. Hafraoui , E. Willems MD, PhD, S. Servais MD, PhD, G. Fillet , Y. Beguin MD, PhD
BJH - volume 5, issue Abstract Book BHS, january 2014
A. Jaspers MD, PhD, F. Baron MD, PhD, E. Willems MD, PhD, K. Hafraoui , C. Bonnet MD, PhD, Y. Beguin MD, PhD
BJH - volume 5, issue Abstract Book BHS, january 2014
F. Baron MD, PhD, M. Lejeune , E. Willems MD, PhD, L. Seidel , K. Hafraoui , S. Servais MD, PhD, A. Jaspers MD, PhD, Y. Beguin MD, PhD
BJH - 2013, issue BHS Abstractbook, january 2013
A. Jaspers MD, PhD, F. Baron MD, PhD, E. Willems MD, PhD, K. Hafraoui , G. Vanstraelen , C. Bonnet MD, PhD, Y. Beguin MD, PhD
BJH - 2013, issue BHS Abstractbook, january 2013
A. Jaspers MD, PhD, F. Baron MD, PhD, E. Willems MD, PhD, E. Wiegerinck , D. Swinkels , Y. Beguin MD, PhD
Top
